Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Lifeloc Technologies ( (LCTC) ).
Lifeloc Technologies has secured $750,000 in financing through a subordinated debenture agreement with Diamond Bridge Capital, aimed at supporting growth initiatives and the commercialization of its SpinDx technology, which promises rapid, cost-effective drug testing. This funding reflects confidence in Lifeloc’s business model and supports its strategy of expanding its product offerings, with plans to integrate SpinDx with their existing alcohol breathalyzer products to develop a marijuana breathalyzer, thus enhancing their market presence and innovation capabilities.
More about Lifeloc Technologies
Lifeloc Technologies, Inc. is a U.S. manufacturer specializing in portable breath alcohol testing devices and related solutions, serving workplace, law enforcement, corrections, and international markets. The company is publicly traded over-the-counter under the symbol LCTC.
YTD Price Performance: 0.36%
Average Trading Volume: 928
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.41M
Find detailed analytics on LCTC stock on TipRanks’ Stock Analysis page.
Trending Articles
- Walmart (NYSE:WMT) Hits Mar-a-Lago to Talk Tariffs
- Ford (NYSE:F) Finds Battery Troubles at Every Turn
- Intel (NASDAQ:INTC) Makes Appearances in More Laptops, Cars
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
